Preliminary use of differential scanning calorimetry of cerebrospinal fluid for the diagnosis of glioblastoma multiforme
Tóm tắt
Thermal stability signatures of complex molecule interaction in biological fluids can be measured using a new approach called differential scanning calorimetry (DSC). The thermal stability of plasma proteome has been described previously as a method of producing a disease-specific “signature,” termed thermogram, in several neoplastic and autoimmune diseases. We describe the preliminary use of DSC performed on cerebrospinal fluid (CSF) as a diagnostic tool for the identification of patients with glioblastoma multiforme (GBM). Samples of CSF from nine patients with confirmed GBM were evaluated using DSC, and the thermogram signatures evaluated. These thermograms were compared with thermograms of CSF taken from patients with non-neoplastic conditions such as head trauma, hydrocephalus, or CSF leak. Further analysis was also performed on CSF from patients who had non-GBM neoplastic conditions such as carcinomatosis meningitis or central nervous system lymphoma or leukemia. The DSC thermograms of CSF of the patients with GBM were significantly different when compared with other neoplastic and non-neoplastic cases. The melting temperature of the major transition was shifted by 5°C, which makes it easily distinguishable from control cases. Our results are very preliminary, but it appears that the DSC of CSF has potential utility in diagnostics and monitoring disease progression in GBM patients.
Tài liệu tham khảo
Steel LF, Shumpert D, Trotter M, Seeholzer SH, Evans AA, London WT, Dwek R, Block TM (2003) A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma. Proteomics 3:601–609
Kennedy S (2001) Proteomic profiling from human samples: the body fluid alternative. Toxicol Lett 120:379–384
Romeo MJ, Espina V, Lowenthal M, Espina BH, Petricoin EF 3rd, Liotta LA (2005) CSF proteome: a protein repository for potential biomarker identification. Expert Rev Proteomics 2:57–70
Liotta LA, Ferrari M, Petricoin E (2003) Clinical proteomics: written in blood. Nature 425:905
Khwaja FW, Reed MS, Olson JJ, Schmotzer BJ, Gillespie GY, Guha A, Groves MD, Kesari S, Pohl J, Van Meir EG (2007) Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients. J Proteome Res 6:559–570
Bruylants G, Wouters J, Michaux C (2005) Differential scanning calorimetry in life science: thermodynamics, stability, molecular recognition and application in drug design. Curr Med Chem 12:2011–2020
Zhou M, Lucas DA, Chan KC, Issaq HJ, Petricoin EF 3rd, Liotta LA, Veenstra TD, Conrads TP (2004) An investigation into the human serum “interactome”. Electrophoresis 25:1289–1298
Garbett NC, Mekmaysy CS, Helm CW, Jenson AB, Chaires JB (2009) Differential scanning calorimetry of blood plasma for clinical diagnosis and monitoring. Exp Mol Pathol 86:186–191
Garbett NC, Miller JJ, Jenson AB, Chaires JB (2008) Calorimetry outside the box: a new window into the plasma proteome. Biophys J 94:1377–1383
Garbett NC, Miller JJ, Jenson AB, Chaires JB (2007) Calorimetric analysis of the plasma proteome. Semin Nephrol 27:621–626
Fish DJ, Brewood GP, Kim JS, Garbett NC, Chaires JB, Benight AS (2010) Statistical analysis of plasma thermograms measured by differential scanning calorimetry. Biophys Chem 152:184–190
Garbett NC, Miller JJ, Jenson AB, Miller DM, Chaires JB (2007) Interrogation of the plasma proteome with differential scanning calorimetry. Clin Chem 53:2012–2014
Spink CH (2008) Differential scanning calorimetry. Methods Cell Biol 84:115–141
Maurer MH, Berger C, Wolf M, Futterer CD, Feldmann RE Jr, Schwab S, Kuschinsky W (2003) The proteome of human brain microdialysate. Proteome Sci 1:7
Li SJ, Peng M, Li H, Liu BS, Wang C, Wu JR, Li YX, Zeng R (2009) Sys-BodyFluid: a systematical database for human body fluid proteome research. Nucleic Acids Res 37:D907–D912
Khwaja FW, Nolen JD, Mendrinos SE, Lewis MM, Olson JJ, Pohl J, Van Meir EG, Ritchie JC, Brat DJ (2006) Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers. Proteomics 6:6277–6287
Gygi SP, Aebersold R (2000) Mass spectrometry and proteomics. Curr Opin Chem Biol 4:489–494